European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

AbbVie Deutschland GmbH & Co. KG, Wiesbaden, Germany

Watch
AbbVie Deutschland GmbH & Co. KG

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Create Dossier
AbbVie Deutschland GmbH & Co. KG

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

AbbVie Deutschland GmbH & Co. KG

Identification

Ut
District Court of Wiesbaden HRA 9790
Sirul
Siren 913945838
Siret
Siret 91394583800013
Lei
549300FI0P3XDOCBXJ78
EUID
DEM1906.HRA9790

Address

Mainzer Str. 81, 65189 Wiesbaden, Germany

Corporate purpose

Research and development, production and processing, and distribution of and trade of chemical, pharmaceutical, diagnostic and medical products as well as nutritional products. The Company is entitled to conduct all transactions which are likely to promote the business, including the establishment and operation of branches, and the acquisition and sale of immovable property and the ordering of liens.

Financial performance

Employees

For this company, Employees numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Marketing & Tech

Network

Loading network

Legal Structure

Current legal representatives Legal form information · Proxy policies Premium
Premium
75Authorized signatory (ppa)
1General partner
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more

Learn more View plans

JOBS AT NORTH DATA

  • Modern Java Developer
Ownership relations Premium + Ownership & Flags add-on
Premium + Ownership & Flags add-on
Shareholders and Investors
4 known active shareholders
Portfolio and Investments
3 known active shareholdings
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more

Learn more View plans

Financials

Key Performance Indicators Financial · Mktg & Tech Premium
Premium
Total assets
Earnings
Earnings CAGR
Revenue
Revenue CAGR
Return on sales
Equity
Equity ratio
Return on equity
Employee number
Revenue per employee
Taxes
Tax ratio
Cash on hand
Receivables
Liabilities
Cost of materials
Wages and salaries
Average salaries per employee
Pension provisions
Real estate
Patents
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more

Learn more View plans
Financial Statements Interactive sheets with CSV/Excel download Premium
Premium
Balance
from 2012 to 2024
Profit & Loss
from 2012 to 2024
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more

Learn more View plans

Publications

29 Apr 2026
Patent: Anti-Hemojuvelin (HJV) Antibodies for the Treatment of Myelofibrosis
10 Nov 2025
Authorized signatory (ppa) (6) · No longer Authorized signatory (ppa) (4)
16 Oct 2025
Wordmark: “SOLISOLV“
1 Oct 2025 via GAG Ludwigshafen am Rhein AG für Wohnungs- also 16/11/2022
Shareholding: GAG Ludwigshafen am Rhein AG für Wohnungs-, Gewerbe- und Städtebau
11 Jul 2025
Authorized signatory (ppa): Johan Martinsson, Robin Max Winkler · No longer Authorized signatory (ppa) (3)
19 Mar 2025
Authorized signatory (ppa) (12) · No longer Authorized signatory (ppa) (3)
3 Mar 2025
No longer Authorized signatory (ppa) (3)
15 Jan 2025 in Sat
State Aid (€100,000 - €500,000): Germany - Evaluation plan for the block exempted R&D tax incentive scheme "Forschungszulagengesetz"
1 Jan 2025 in Fk
Public funding (€140,000): PROXIDRUGS: Advanced Assay and Screening Platform for the Identification and Characterization of Proxidrugs (ProxiDETECT) - B
30 Dec 2024
Authorized signatory (ppa): Ch. Poennighaus · No longer Authorized signatory (ppa): Marco Fröhlich
28 Dec 2024 in Fk
Public funding (€32,160): PROXIDRUGS: Targeted delivery of PROXIDRUGS in the human body (BioDEL) - D
20 Dec 2024
Authorized signatory (ppa): Henning Kleine, Kerstin Sauer · No longer Authorized signatory (ppa) (4)
1 Nov 2024 in Hor
EU funding: Advancing Safe and Sustainable by design Practices in Pharmaceutical Manufacturing
17 Sept 2024
Annual report for the year ending 31/12/2023 · Balance sheet for 31/12/2023 · Earnings statement for 31/12/2023 · Shareholdings: AbbVie Komplementär GmbH, Aktiengesellschaft für Wohnungs-, Gewerbe …
27 Aug 2024
Authorized signatory (ppa): Bernhard H. Dodell
17 Jul 2024 via AnalytiCon Discovery GmbH
EU funding (€260,539): Macrocycles for Drug Discovery
11 Jul 2024
Authorized signatory (ppa): Katrin Hesse · No longer Authorized signatory (ppa) (1)
2 Jul 2024
Authorized signatory (ppa): P. Rangel Cunha
30 Apr 2024
No longer Authorized signatory (ppa) (1)
26 Feb 2024
Annual report for the year ending 31/12/2022 · Balance sheet for 31/12/2022 · Earnings statement for 31/12/2022 · Shareholdings (5 companies)
9 Feb 2024
Authorized signatory (ppa): Benedict O. Ogola · Limited Partner: AbbVie Inc
8 Feb 2024
Wordmark: “Meltrex“
21 Dec 2023
Authorized signatory (ppa): Waldtraut Petermann
4 Dec 2023
Authorized signatory (ppa) (4) · No longer Authorized signatory (ppa) (4)
31 Aug 2023
Patent: N-Methyl-4-(quinolin-2-yl)pyridin-2-amine compounds
22 Aug 2023
Authorized signatory (ppa): Stefanie Hauck, Maurice G. C. Saes
28 Jul 2023
Patent: Anti-Garp-TGF-Beta1/PD-1 Combination Therapy
6 Jul 2023
Authorized signatory (ppa) (2) · No longer Authorized signatory (ppa) (1)
28 Jun 2023 via King's College London UNIVERSITY
EU funding: Artificial intelligence-based Parkinson’s disease risk assessment and prognosis
24 May 2023
Authorized signatory (ppa) (4) · No longer Authorized signatory (ppa) (2)
1 May 2023 in Hor
EU funding: GUIding multi-moDal thErapies against MRD by liquid biopsies - GUIDE.MRD
21 Apr 2023
Authorized signatory (ppa) (6) · No longer Authorized signatory (ppa) (7)
13 Apr 2023
No longer Authorized signatory (ppa): Markus D. P. Merten · Authorized signatory (ppa) (4)
6 Mar 2023
Patent: Combinations with an Anti Human CD39 Antibody, an Anti Human PD-1 Antibody, and Chemotherapy in Gastric Cancer
1 Feb 2023
Authorized signatory (ppa) (1)
27 Jan 2023
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (2)
16 Nov 2022
Patent: Methods for Treating Anemia of Kidney Disease
7 Oct 2022
Annual report for the year ending 31/12/2021 · Balance sheet for 31/12/2021 · Earnings statement for 31/12/2021 · Shareholdings: % der Anteile an der AbbVie Komplementär GmbH, % der im Geschäftsjahr …
29 Sept 2022
Authorized signatory (ppa) (1)
16 Sept 2022
Word figurative mark: “xellex xellex“
31 Aug 2022
Authorized signatory (ppa): Ute Klöckner
6 Jul 2022
Authorized signatory (ppa) (4) · No longer Authorized signatory (ppa) (1)
11 May 2022
Authorized signatory (ppa) (4) · No longer Authorized signatory (ppa) (3)
10 May 2022
Original document: “Liste der Gesellschafter“
10 May 2022
Original document: “Liste der Gesellschafter“
10 May 2022
Original document: “Liste der Gesellschafter“
10 May 2022
Original document: “Liste der Gesellschafter“
10 May 2022
Original document: “Liste der Gesellschafter“
10 May 2022
Original document: “Liste der Gesellschafter“
2 May 2022
Merger: Allergan GmbH
1 May 2022 in France
Address · Legal form: Société étrangère non immatriculée au RCS · Name: ABBVIE DEUTSCHLAND GMBH & CO. KG · Segment clas­si­fi­ca­tion
8 Apr 2022
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
6 Apr 2022
No longer Authorized signatory (ppa) (2) · Authorized signatory (ppa) (1)
11 Mar 2022
Authorized signatory (ppa): Markus Gstettner, Andreas Holler
17 Feb 2022
Annual report for the year ending 31/12/2020 · Balance sheet for 31/12/2020 · Earnings statement for 31/12/2020
6 Jan 2022
Patent: Methods of Treating Crohn's Disease and Ulcerative Colitis
3 Jan 2022
Authorized signatory (ppa): Sina Nadine Noske · No longer Authorized signatory (ppa) (1)
6 Dec 2021 as AbbVie GmbH & Co. KG
Original document: “Liste der Gesellschafter“
Year 2021 in Epobase
7 European patent filings: Spiro-Cyclic Amine Derivatives AS S1P Modulators …
27 Oct 2021
Authorized signatory (ppa): Sebastian Wachtarz · No longer Authorized signatory (ppa) (5)
1 Oct 2021 in Fk
Public funding (€69,439): PROXIDRUGS: An Assay and Screening Platform for Molecular Degraders (ProxiDETECT) - B
1 Oct 2021 in Fk
Public funding (€32,426): PROXIDRUGS: Validation of molecular degraders in neuronal models (AntiDEG) - B
1 Oct 2021 in Fk
Public funding (€24,003): PROXIDRUGS: Overcoming Biological Barriers to Proxidrug Delivery (BioDEL) - D
12 Jul 2021
No longer Authorized signatory (ppa) (1)
11 Jun 2021
Authorized signatory (ppa) (2) · No longer Authorized signatory (ppa) (1)
7 Apr 2021
Authorized signatory (ppa) (2) · No longer Authorized signatory (ppa) (1)
9 Mar 2021
Authorized signatory (ppa) (11) · No longer Authorized signatory (ppa) (3)
25 Jan 2021
Authorized signatory (ppa): Andreas Rudolf Beck
24 Nov 2020
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019 · Earnings statement for 31/12/2019
Year 2020 in Epobase
5 European patent filings: Dosing Regimens for USE in Treating Myelofibrosis and MPN-Related Disorders with Navitoclax …
20 Oct 2020
Authorized signatory (ppa): Elena Rajňáková
16 Oct 2020
No longer Authorized signatory (ppa) (1)
15 Sept 2020
Original document: “Liste der Gesellschafter“
22 Jul 2020
Authorized signatory (ppa): Silke Weber · No longer Authorized signatory (ppa) (1)
10 Jun 2020
Authorized signatory (ppa) (2) · No longer Authorized signatory (ppa) (1)
30 Apr 2020
No longer Authorized signatory (ppa) (2)
10 Mar 2020
Authorized signatory (ppa) (4)
10 Feb 2020
Authorized signatory (ppa): Tim Stürzenacker
27 Jan 2020
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (4)
11 Nov 2019
Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018 · Shareholdings (4 companies)
8 Nov 2019
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (2)
15 Oct 2019
Original document: “Gesellschaftsvertrag / Satzung / Statut“
9 Sept 2019
Authorized signatory (ppa) (1) · No longer Authorized signatory (ppa) (1)
27 Jun 2019
Authorized signatory (ppa) (2)
17 May 2019
Authorized signatory (ppa) (11) · No longer Authorized signatory (ppa) (4)
Year 2019 in Epobase
7 European patent filings: Aminotetraline and Aminoindane Derivatives, Pharmaceutical Compositions Containing Them, and Their USE in Therapy …
1 Mar 2019
No longer Authorized signatory (ppa) (3)
18 Feb 2019
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017 · Earnings statement for 31/12/2017
1 Feb 2019
Authorized signatory (ppa) (4) · No longer Authorized signatory (ppa) (1)
Year 2018 in Epobase
16 European patent filings: Isoindoline Derivatives, Pharmaceutical Compositions Containing Them, and Their USE in Therapy …
30 Nov 2018
No longer Authorized signatory (ppa) (1)
18 Oct 2018
Authorized signatory (ppa) (1) · No longer Authorized signatory (ppa) (1)
9 Oct 2018
Patent: Verfahren zur Herstellung einer Festen Dispersion eines Wirkstoffes
18 Sept 2018
Authorized signatory (ppa) (1)
19 Jul 2018
No longer Authorized signatory (ppa) (1)
19 Apr 2018
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (2)
Year 2017 in Epobase
23 European patent filings: Method for Producing Ultrafine Submicronic Suspensions …
5 Dec 2017
Authorized signatory (ppa) (6) · No longer Authorized signatory (ppa) (6)
20 Nov 2017
Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016 · Earnings statement for 31/12/2016 · Shareholdings: AbbVie Komplementär GmbH, Aktiengesellschaft für Wohnungs-, Gewerbe …
Year 2017 in Dpmap
4 patent filings: Substituted benzimidazoles, their production and use …
Year 2017 in Euipods
6 registered designs
19 Jul 2017
Authorized signatory (ppa) (1)
12 Apr 2017
No longer Authorized signatory (ppa) (2) · Authorized signatory (ppa) (1)
9 Mar 2017
Authorized signatory (ppa) (5) · No longer Authorized signatory (ppa) (1)
1 Mar 2017 in Hor
EU funding: Inhibiting Misfolded protein PRopagation in Neurodegenerative Diseases - Sofia ref.: 116060
1 Jan 2017 in Hor
EU funding: Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106
1 Jan 2017 in Hor
EU funding: Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030
Year 2016 in Epobase
29 European patent filings: Heterocyclic Compounds and Their USE AS Glycogen Synthase Kinase-3 Inhibitors …
23 Dec 2016
No longer Authorized signatory (ppa) (4) · Authorized signatory (ppa) (1)
1 Nov 2016 in Hor
EU funding: Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976
1 Oct 2016 in Hor
EU funding: Alzheimers Disease Apolipoprotein Pathology for Treatment Elucidation and Development - Sofia ref.: 115975
29 Sept 2016
No longer Authorized signatory (ppa) (3) · Authorized signatory (ppa) (2)
5 Sept 2016
Annual report for the year ending 31/12/2015 · Balance sheet for 31/12/2015 · Earnings statement for 31/12/2015 · Shareholding: 100% der Anteile an der AbbVie Komplementär GmbH, die Komplementärin …
29 Jun 2016
Original document: “Gesellschaftsvertrag / Satzung / Statut“
16 Jun 2016
Authorized signatory (ppa) (3)
17 Mar 2016
Patent: 4,5-Dihydropyrazolderivate, Pharmazeutische Zusammensetzungen Damit und deren Verwendung in der Therapie
17 Mar 2016
Patent: 4,5-Dihydropyrazolderivate, Pharmazeutische Zusammensetzungen Damit und deren Verwendung in der Therapie
17 Mar 2016
Patent: 4,5-Dihydropyrazolderivate, Pharmazeutische Zusammensetzungen Damit und deren Verwendung in der Therapie
3 Mar 2016
No longer Authorized signatory (ppa) (2) · Authorized signatory (ppa) (2)
5 Jan 2016
No longer Authorized signatory (ppa) (4)
9 Dec 2015
No longer Authorized signatory (ppa) (2) · Authorized signatory (ppa) (1)
Year 2015 in Dpmap
10 patent filings
Year 2015 in Epobase
14 European patent filings: Monoclonal Antibodies Against the RGM a Protein for USE in the Treatment of Retinal Nerve Fiber Layer Degeneration …
1 Sept 2015 in Fk
Public funding (€398,969): EPC-based carrier systems for the specific transport of CNS therapeutics across the blood-brain barrier (EPC-BBB) - Subproject: Determination of physicochemical and galenic …
31 Jul 2015
Authorized signatory (ppa) (2)
3 Jun 2015
Authorized signatory (ppa): Georg Hoffmann
15 May 2015
Annual report for the year ending 31/12/2014 · Balance sheet for 31/12/2014 · Earnings statement for 31/12/2014
19 Mar 2015
No longer Authorized signatory (ppa) (1)
10 Feb 2015
Original document: “Gesellschaftsvertrag / Satzung / Statut“
10 Feb 2015
Original document: “Gesellschaftsvertrag / Satzung / Statut“
12 Jan 2015
Annual report for the year ending 31/12/2013 · Balance sheet for 31/12/2013 · Earnings statement for 31/12/2013 · Shareholding: 100% der Anteile an der AbbVie Komplementär GmbH, die Komplementärin …
Year 2014 in Epobase
21 European patent filings: Oxindole Derivatives Carrying a Piperidyl-Substituted Azetidinyl Substituent and USE Thereof for Treating Vasopressine-Related Diseases …
7 Nov 2014
No longer Authorized signatory (ppa) (3) · Authorized signatory (ppa) (1)
Year 2014 in Dpmap
29 patent filings: Acylaminocycloalkylverbindungen zur Behandlung von Erkrankungen, die auf die Modulation des Dopamin-D3-Rezeptors Ansprechen …
5 Sept 2014
Original document: “Gesellschaftsvertrag / Satzung / Statut“
21 Jul 2014
Original document: “Liste der Gesellschafter“
15 May 2014
Authorized signatory (ppa) (1)
9 Apr 2014
Annual report for the year ending 31/12/2012 · Balance sheet for 31/12/2012 · Earnings statement for 31/12/2012 · Shareholding: 100 % der Anteile an der AbbVie Komplementär GmbH
19 Feb 2014
Authorized signatory (ppa): Fabian Schmidt
30 Jan 2014
Address
Year 2014 in Dpmam
10 trademark filings: Meltrex, Soliqs, Striaton, Xellex, Xtec, solid drops …
Year 2013 in Epobase
18 European patent filings: Substituted 2-Phenylbenzimidazoles and Their use as Parp Inhibitors …
Year 2013 in Dpmap
13 patent filings: Isoindolinderivate, Pharmazeutische Zusammensetzungen Damit und Ihre Therapeutische Verwendung …
26 Jul 2013
Authorized signatory (ppa): Joanna E. Schmidt
17 Jul 2013
Authorized signatory (ppa): Joanna E. Schmidt
3 Jul 2013
No longer Authorized signatory (ppa) (4) · Authorized signatory (ppa) (2)
25 Jun 2013
No longer Authorized signatory (ppa) (4) · Authorized signatory (ppa) (2)
21 Dec 2012
Authorized signatory (ppa) (1)
Year 2012 in Epobase
8 European patent filings: Composition and Method for the Diagnosis and Treatment of Iron-Related Disorders …
23 Nov 2012
Address
7 Nov 2012
Authorized signatory (ppa) (38)
7 Nov 2012
Address · Sub­sidiary: 67061 Ludwigshafen,;
2 Nov 2012 via Abbott GmbH & Co. KG
Acquisition, Break-up: Abbott GmbH & Co. KG
2 Nov 2012
Acquisition: Abbott GmbH & Co. KG · Break-up: Abbott GmbH & Co. KG
1 Oct 2012 in Fk
Public funding (€792,808): CI3: Identification of neuroprotective, neuroregenerative molecular markers for the treatment of multiple sclerosis-associated neurodegeneration
4 Sept 2012
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
Year 2012 in Dpmap
8 patent filings: 1-(Pyridin-2-yl)-3-(Chinolin-4-yl)Harnstoff-Derivate und verwandte Verbindungen als Glykogen-Synthase Kinase 3 (GSK-3) Inhibitoren zur Behandlung von neurodegenerativen Erkrankungen …
11 Jun 2012
Reg­is­tra­tion · General partner: AbbVie Komplementär GmbH · Address · Proxy policy · Corporate Purpose
Year 2012 in Dpmam
10 trademark filings: Meltrex, Soliqs, Striaton, Xellex, Xtec, solid drops …
Year 2011 in Epobase
9 European patent filings: 1-(Quinolin-4-YL)-3-(6-(Trifluoromethyl)-Pyridin-2-YL)Urea and 1-(Quinolin-4-YL)-3-(6-(Trifluoromethyl)-Pyrazine-2-YL)Urea Derivatives AS Glycogen Synthase Kinase 3 (GSK-3) …
There are no publications matching your search.

Mentions

15 Feb 2026 in Rne
Reg­is­tra­tion: 01/05/2022 · Segment clas­si­fi­ca­tion · Corporate Purpose
10 Nov 2025 in Ler
Direct parent
10 Nov 2025 in Ler
Ultimate parent
16 Aug 2018 in Hrdk
Health Innovation Hub & Holding GmbH: “Liste der Gesellschafter“
23 Aug 2012 in Hrdk also 21/08/2012
AbbVie Komplementär GmbH: “Liste der Gesellschafter“
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.